Author details

Full Name

Garrett T Graham

Affiliation

ORCID

Career Start Year

2014

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37072468	Results and lessons learned from the sbv IMPROVER metagenomics diagnostics for inflammatory bowel disease challenge.	Sci Rep	2023
35047826	Comprehensive profiling of mRNA splicing indicates that GC content signals altered cassette exon inclusion in Ewing sarcoma.	NAR Cancer	2022
34133426	Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells.	PLoS One	2021
34135000	An AIB1 Isoform Alters Enhancer Access and Enables Progression of Early-Stage Triple-Negative Breast Cancer.	Cancer Research	2021
32709938	Sierra Nevada sweep: metagenomic measurements of bioaerosols vertically distributed across the troposphere.	Scientific Reports	2020
32016454	Development of an Ewing sarcoma cell line with resistance to EWSâ¿¿FLI1 inhibitor YKâ¿¿4â¿¿279.	Mol Med Rep	2020
31959914	Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH.	Cell Death Differ	2020
31788936	Loss of ANCO1 repression at AIB1/YAP targets drives breast cancer progression.	EMBO Reports	2020
31392992	EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.	Nucleic Acids Res	2019
31796844	Somatic mutation signatures in primary liver tumors of workers exposed to ionizing radiation.	Sci Rep	2019
30563830	A Mechanism of Resistance to Antibody-Targeted Immune Attack.	Cancer Immunol Res	2019
31182435	The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents.	Clin Cancer Res	2019
31451564	Short- and Long-Term Effects of CDK4/6 Inhibition on Early-Stage Breast Cancer.	Mol Cancer Ther	2019
31447265	A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.	Developmental Cell	2019
31164413	The Sustained Induction of c-MYC Drives Nab-Paclitaxel Resistance in Primary Pancreatic Ductal Carcinoma Cells.	Mol Cancer Res	2019
30934798	Single-Molecule Real-Time (SMRT) Full-Length RNA-Sequencing Reveals Novel and Distinct mRNA Isoforms in Human Bone Marrow Cell Subpopulations.	Genes (Basel)	2019
29740146	Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma.	Scientific Reports	2018
30166462	Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors.	Science	2018
30447903	Reprint of: Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.	Cancer Genet	2018
30131435	Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E.	Cancer Prev Res (Phila)	2018
29651165	The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer.	Cell Death Differ	2018
27546622	Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.	Oncogene	2017
28974650	Inhibition of the oncogenic fusion protein EWS-FLI1 causes G<sub>2</sub>-M cell cycle arrest and enhanced vincristine sensitivity in Ewing's sarcoma.	Sci Signal	2017
29153095	Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer.	Cancer Genet	2017
27818180	Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression.	Dev Cell	2016
27137931	Ezrin Inhibition Up-regulates Stress Response Gene Expression.	J Biol Chem	2016
25564528	RNA helicase A activity is inhibited by oncogenic transcription factor EWS-FLI1.	Nucleic Acids Res	2015
25714835	Multifactorial analysis of conditional reprogramming of human keratinocytes.	PLoS One	2015
25737553	Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing.	Proc Natl Acad Sci U S A	2015
24803537	Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.	Sci Signal	2014
24947929	PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma.	Clin Cancer Res	2014